Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Fallon Esther Chipidza, M.D.

Concepts (73)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Merkel Cell120203290.530 Why?
Diagnostic Techniques and Procedures120162190.460 Why?
Lymphoma, Non-Hodgkin1202113760.450 Why?
Mastectomy2202118500.440 Why?
Anger120164050.440 Why?
Hodgkin Disease1202113840.440 Why?
Lymphoma, Large B-Cell, Diffuse1202114370.370 Why?
Prostatic Neoplasms52023112300.300 Why?
Radiotherapy, Adjuvant3202317930.290 Why?
Zimbabwe320211350.280 Why?
Skin Neoplasms1202058640.180 Why?
Breast Neoplasms32021211880.170 Why?
Delivery of Health Care1201653750.150 Why?
Botswana1202110650.150 Why?
Prostate-Specific Antigen2202324870.140 Why?
Multiple Pulmonary Nodules120181750.130 Why?
Radiation Oncology120215720.120 Why?
Kaplan-Meier Estimate2202065470.100 Why?
Retrospective Studies82023819030.100 Why?
Data Collection1202133240.100 Why?
Aggression120167500.090 Why?
Patient Compliance1202127010.090 Why?
Neoplasm Staging32020112620.090 Why?
Cancer Care Facilities220244280.080 Why?
Tumor Suppressor Protein p531202029600.080 Why?
High-Throughput Nucleotide Sequencing1202136710.080 Why?
Proportional Hazards Models22020125620.080 Why?
Radiosurgery1201713460.070 Why?
Carcinoma, Pancreatic Ductal1201817560.070 Why?
Tumor Microenvironment1202039520.070 Why?
Drug Prescriptions1201616730.070 Why?
Mutation22021302660.070 Why?
Prognosis32022300460.060 Why?
Humans1620247689700.060 Why?
Gene Expression Regulation, Neoplastic1202186640.060 Why?
Prostate2202317810.060 Why?
Adjuvants, Pharmaceutic12023480.060 Why?
Neoplasms22024223890.060 Why?
Lung Neoplasms22018135940.050 Why?
Physician-Patient Relations1201632690.050 Why?
Neoadjuvant Therapy2202329090.050 Why?
Pancreatic Neoplasms1201854430.040 Why?
Analgesics, Opioid1201638380.040 Why?
Health Services Misuse120212490.040 Why?
Carcinoma, Non-Small-Cell Lung1201754340.040 Why?
Salvage Therapy1202312770.030 Why?
Male820233652030.030 Why?
Survival Rate22021128730.030 Why?
Prostatectomy1202318410.030 Why?
SEER Program1202014730.030 Why?
Risk Assessment12016243330.030 Why?
Needs Assessment1202011430.030 Why?
Treatment Outcome12020654800.030 Why?
DNA Repair1202220540.030 Why?
Female520213975150.020 Why?
Artificial Intelligence1202426660.020 Why?
Middle Aged520212237370.020 Why?
Healthcare Disparities1202434210.020 Why?
Risk1202096210.020 Why?
Aged420201717860.020 Why?
Palliative Care1202136440.020 Why?
Neoplasm Recurrence, Local1202394420.020 Why?
Clinical Trials as Topic1202080550.010 Why?
Age Factors12020184350.010 Why?
Health Services Accessibility1202155220.010 Why?
Incidence12020215470.010 Why?
Follow-Up Studies12021393940.010 Why?
Case-Control Studies12017222960.010 Why?
Cohort Studies12020418080.010 Why?
Tomography, X-Ray Computed12018207760.010 Why?
Adult220212238510.010 Why?
Risk Factors12021749760.010 Why?
United States12020731860.010 Why?
Chipidza's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Co-Authors (53)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.